Disclosure of individual genetic data to research participants: the debate reconsidered

A.L. Bredenoord; H.Y. Kroes; E. Cuppen; M. Parker; J.J.M. van Delden

doi:10.1016/j.tig.2010.11.004

Disclosure of individual genetic data to research participants: the debate reconsidered

A.L. Bredenoord, H.Y. Kroes, E. Cuppen, M. Parker, J.J.M. van Delden

Hubrecht Institute

Onderzoeksoutput: Bijdrage aan wetenschappelijk tijdschrift/periodieke uitgave › Artikel › Wetenschappelijk › peer review

175 Citaten (Scopus)

Samenvatting

Despite extensive debate, there is no consensus on whether individual genetic data should be disclosed to research participants. The emergence of whole-genome sequencing methods is increasingly generating unequalled amounts of genetic data, making the need for a clear feedback policy even more urgent. In this debate two positions can be broadly discerned: a restrictive disclosure policy ('no feedback except life-saving data') and an intermediate policy of qualified disclosure ('feedback if the results meet certain conditions'). We explain both positions and present the principal underlying arguments. We suggest that the debate should no longer address whether genetic research results should be returned, but instead how best to make an appropriate selection and how to strike a balance between the possible benefits of disclosure and the harms of unduly hindering biomedical research.

Originele taal-2	Engels
Pagina's (van-tot)	41-47
Tijdschrift	Trends in Genetics
Volume	27
Nummer van het tijdschrift	2
DOI's	https://doi.org/10.1016/j.tig.2010.11.004
Status	Gepubliceerd - 2010

Toegang tot document

10.1016/j.tig.2010.11.004

Citeer dit

@article{b23ae402a6a8415a94b0cf4531945a08,

title = "Disclosure of individual genetic data to research participants: the debate reconsidered",

abstract = "Despite extensive debate, there is no consensus on whether individual genetic data should be disclosed to research participants. The emergence of whole-genome sequencing methods is increasingly generating unequalled amounts of genetic data, making the need for a clear feedback policy even more urgent. In this debate two positions can be broadly discerned: a restrictive disclosure policy ('no feedback except life-saving data') and an intermediate policy of qualified disclosure ('feedback if the results meet certain conditions'). We explain both positions and present the principal underlying arguments. We suggest that the debate should no longer address whether genetic research results should be returned, but instead how best to make an appropriate selection and how to strike a balance between the possible benefits of disclosure and the harms of unduly hindering biomedical research.",

author = "A.L. Bredenoord and H.Y. Kroes and E. Cuppen and M. Parker and {van Delden}, J.J.M.",

note = "Reporting year: 2010",

year = "2010",

doi = "10.1016/j.tig.2010.11.004",

language = "English",

volume = "27",

pages = "41--47",

journal = "Trends in Genetics",

issn = "0168-9525",

publisher = "Elsevier B.V.",

number = "2",

}

TY - JOUR

T1 - Disclosure of individual genetic data to research participants: the debate reconsidered

AU - Bredenoord, A.L.

AU - Kroes, H.Y.

AU - Cuppen, E.

AU - Parker, M.

AU - van Delden, J.J.M.

N1 - Reporting year: 2010

PY - 2010

Y1 - 2010

N2 - Despite extensive debate, there is no consensus on whether individual genetic data should be disclosed to research participants. The emergence of whole-genome sequencing methods is increasingly generating unequalled amounts of genetic data, making the need for a clear feedback policy even more urgent. In this debate two positions can be broadly discerned: a restrictive disclosure policy ('no feedback except life-saving data') and an intermediate policy of qualified disclosure ('feedback if the results meet certain conditions'). We explain both positions and present the principal underlying arguments. We suggest that the debate should no longer address whether genetic research results should be returned, but instead how best to make an appropriate selection and how to strike a balance between the possible benefits of disclosure and the harms of unduly hindering biomedical research.

AB - Despite extensive debate, there is no consensus on whether individual genetic data should be disclosed to research participants. The emergence of whole-genome sequencing methods is increasingly generating unequalled amounts of genetic data, making the need for a clear feedback policy even more urgent. In this debate two positions can be broadly discerned: a restrictive disclosure policy ('no feedback except life-saving data') and an intermediate policy of qualified disclosure ('feedback if the results meet certain conditions'). We explain both positions and present the principal underlying arguments. We suggest that the debate should no longer address whether genetic research results should be returned, but instead how best to make an appropriate selection and how to strike a balance between the possible benefits of disclosure and the harms of unduly hindering biomedical research.

U2 - 10.1016/j.tig.2010.11.004

DO - 10.1016/j.tig.2010.11.004

M3 - Article

SN - 0168-9525

VL - 27

SP - 41

EP - 47

JO - Trends in Genetics

JF - Trends in Genetics

IS - 2

ER -

Disclosure of individual genetic data to research participants: the debate reconsidered

Samenvatting

Toegang tot document

Vingerafdruk

Citeer dit